YCM
RPRX icon

Yousif Capital Management’s Royalty Pharma RPRX Stock Holding History

Yousif Capital Management’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$389K Sell
6,939
-15
-0.2% -$781 ﹤0.01% 1425
2026
Q1 		$334K Buy
6,954
+1,617
+30% +$70.8K ﹤0.01% 1586
2025
Q4 		$209K Buy
+5,337
New +$204K ﹤0.01% 1782
2025
Q2 		– Sell
-8,824
Closed -$275K – 1923
2025
Q1 		$275K Buy
+8,824
New +$280K ﹤0.01% 1685

Other funds holding RPRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Mitsubishi UFJ Trust & Banking
Mitsubishi UFJ Trust & Banking Tokyo, Japan $45.7B AUM 34.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Yousif Capital Management's RPRX Position: Q2 2026 in Review

Yousif Capital Management reduced its Royalty Pharma (RPRX) stake by 0.22% in Q2 2026, selling an estimated $781 and leaving 6,939 shares worth $389K. The position accounts for ﹤0.01% of the portfolio, ranked #1425.

Yousif Capital Management first reported a position in RPRX in Q1 2025 and has held it in 4 quarters since. 299 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Yousif Capital Management held 6,939 shares of Royalty Pharma worth $389K as of Q2 2026.
  • Yousif Capital Management sold 15 Royalty Pharma shares in Q2 2026, an estimated $781.
  • Royalty Pharma made up ﹤0.01% of Yousif Capital Management's portfolio in Q2 2026, its #1425 holding.
  • Yousif Capital Management first reported a position in Royalty Pharma in Q1 2025 and has held it in 4 quarters since.
  • 299 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Yousif Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.